In a 32-year-old woman with rheumatoid arthritis and a family history of systemic lupus who has had worsening lower abdominal pressure for two months, urinary symptoms that improved with amitriptyline, normal vital signs, no fever, no vaginal discharge, normal laboratory studies, no pyuria, no costovertebral angle tenderness, and exquisite tenderness over the pelvic floor on examination, what is the most likely diagnosis?

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

The most likely diagnosis is interstitial cystitis/bladder pain syndrome (IC/BPS), given the chronic lower abdominal pressure lasting over 6 weeks, urinary symptoms that responded to amitriptyline, exquisite pelvic floor tenderness on examination, and the absence of infection or other identifiable causes. 1

Diagnostic Reasoning

This patient meets the AUA diagnostic criteria for IC/BPS, which defines the condition as an unpleasant bladder-related sensation (pain, pressure, or discomfort) accompanied by lower urinary tract symptoms lasting > 6 weeks, in the absence of infection or any other identifiable cause. 1

Key Clinical Features Supporting IC/BPS:

• Symptom duration: Two months of worsening lower abdominal pressure exceeds the required 6-week threshold for IC/BPS diagnosis 1

• Pain characteristics: Lower abdominal pressure is a typical presentation in women with IC/BPS, where pain locations commonly include the suprapubic area, urethra, vulva, vagina, rectum, lower abdomen, and back 1

• Pelvic floor tenderness: Exquisite tenderness over the pelvic floor on examination is characteristic of IC/BPS and supports the diagnosis 2

• Therapeutic response: The improvement of urinary symptoms with amitriptyline is highly consistent with IC/BPS, as amitriptyline is a recommended second-line oral therapy for this condition 2, 3

• Exclusion of other causes: Normal vital signs, absence of fever, no vaginal discharge, no pyuria, no hematuria, and normal laboratory studies effectively rule out urinary tract infection, sexually transmitted infections, and other infectious etiologies 1

Important Differential Considerations:

While the patient has rheumatoid arthritis and a family history of systemic lupus erythematosus, lupus cystitis is unlikely in this case because:

• Lupus cystitis typically presents with severe systemic manifestations including bilateral hydronephrosis, paralytic ileus, ascites, and thickened bladder wall on imaging 4, 5
• This patient has normal vital signs and no evidence of acute systemic illness
• Lupus cystitis is strongly associated with gastrointestinal involvement (abdominal pain, nausea, vomiting, diarrhea) occurring simultaneously with bladder symptoms 5
• The patient's urinary symptoms improved with amitriptyline, whereas lupus cystitis requires high-dose corticosteroid therapy (typically methylprednisolone pulse therapy followed by 60 mg/day prednisolone) 4

Clinical Management Approach

Confirming the Diagnosis:

• Document that bladder-related pain/pressure has persisted > 6 weeks 1
• Verify the relationship of symptoms to bladder filling and whether they improve after voiding 1
• Assess urinary frequency (typically > 8 voids per day) and nocturia episodes 1
• Confirm negative urine cultures to exclude infection 1

Treatment Strategy:

Since the patient has already responded to amitriptyline (a second-line therapy), continue amitriptyline therapy as it has proven effective for her urinary symptoms. 2, 3

• Amitriptyline is effective for treating both men and women with urinary frequency and pelvic/suprapubic pain syndromes 3
• The therapeutic response is durable, but the medication dose must be maintained, as symptoms typically return early when patients attempt to taper off 3
• Consider adding manual physical therapy techniques targeting the pelvic floor, given the exquisite pelvic floor tenderness 2

Important Caveats:

• Do not delay diagnosis: Definitions requiring symptom duration ≥ 6 months (used in research settings) should be avoided in routine practice, as they delay diagnosis and treatment initiation 1

• Pain management: Should be considered throughout the course of therapy with the goal of maximizing function and minimizing pain and side effects 2

• Rheumatoid arthritis consideration: While patients with RA have increased prevalence of lower urinary tract symptoms (94.4% have at least one LUTS symptom), the specific presentation here—with pelvic floor tenderness and response to amitriptyline—is most consistent with IC/BPS rather than RA-related bladder dysfunction 6